Carsten Golletz

726 total citations
7 papers, 441 citations indexed

About

Carsten Golletz is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Carsten Golletz has authored 7 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in Carsten Golletz's work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Epigenetics and DNA Methylation (2 papers). Carsten Golletz is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Epigenetics and DNA Methylation (2 papers). Carsten Golletz collaborates with scholars based in Germany, Taiwan and Austria. Carsten Golletz's co-authors include Glen Kristiansen, Dimo Dietrich, Heidrun Gevensleben, Peter Brossart, Timo Vogt, Jennifer Landsberg, Friedrich Bootz, Thore Thiesler, Johannes Stein and Klaus Jung and has published in prestigious journals such as The Journal of Immunology, Clinical Cancer Research and Human Reproduction.

In The Last Decade

Carsten Golletz

7 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carsten Golletz Germany 7 234 209 150 131 66 7 441
Yalun Li China 12 164 0.7× 82 0.4× 117 0.8× 163 1.2× 35 0.5× 39 412
A. Athanassiades Greece 9 157 0.7× 91 0.4× 101 0.7× 54 0.4× 169 2.6× 11 398
Ahmed El‐Balat Germany 10 208 0.9× 66 0.3× 118 0.8× 72 0.5× 81 1.2× 34 426
Л. А. Коломиец Russia 13 118 0.5× 78 0.4× 196 1.3× 37 0.3× 78 1.2× 95 426
Longhao Sun China 10 161 0.7× 80 0.4× 192 1.3× 68 0.5× 17 0.3× 21 428
Christina Alidousty Germany 12 116 0.5× 72 0.3× 209 1.4× 104 0.8× 10 0.2× 18 408
Meilian Dong China 10 172 0.7× 82 0.4× 121 0.8× 51 0.4× 34 0.5× 17 369
Damian J. Ralser Germany 11 110 0.5× 51 0.2× 132 0.9× 73 0.6× 17 0.3× 35 325
Hualei Bu China 11 118 0.5× 36 0.2× 173 1.2× 54 0.4× 38 0.6× 24 354
Junchen Gu United States 6 260 1.1× 108 0.5× 74 0.5× 56 0.4× 158 2.4× 7 437

Countries citing papers authored by Carsten Golletz

Since Specialization
Citations

This map shows the geographic impact of Carsten Golletz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Golletz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Golletz more than expected).

Fields of papers citing papers by Carsten Golletz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Golletz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Golletz. The network helps show where Carsten Golletz may publish in the future.

Co-authorship network of co-authors of Carsten Golletz

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Golletz. A scholar is included among the top collaborators of Carsten Golletz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Golletz. Carsten Golletz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Kraus, Dominik, et al.. (2021). Zona Pellucida Protein 2 (ZP2) Is Expressed in Colon Cancer and Promotes Cell Proliferation. Cancers. 13(8). 1759–1759. 8 indexed citations
3.
Goltz, Diane, Heidrun Gevensleben, Timo Vogt, et al.. (2018). CTLA4 methylation predicts response to anti–PD-1 and anti–CTLA-4 immunotherapy in melanoma patients. JCI Insight. 3(13). 74 indexed citations
4.
Windsperger, Karin, Sabine Dekan, Sophie Pils, et al.. (2017). Extravillous trophoblast invasion of venous as well as lymphatic vessels is altered in idiopathic, recurrent, spontaneous abortions. Human Reproduction. 32(6). 1208–1217. 80 indexed citations
5.
Franzen, Alina, Timo Vogt, Tim Müller, et al.. (2017). PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas. Oncotarget. 9(1). 641–650. 51 indexed citations
6.
Gevensleben, Heidrun, Dimo Dietrich, Carsten Golletz, et al.. (2015). The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer. Clinical Cancer Research. 22(8). 1969–1977. 167 indexed citations
7.
König, Katharina, Linda Diehl, Ursula Rommerscheidt‐Fuss, et al.. (2010). Four-and-a-Half LIM Domain Protein 2 Is a Novel Regulator of Sphingosine 1-Phosphate Receptor 1 in CCL19-Induced Dendritic Cell Migration. The Journal of Immunology. 185(3). 1466–1475. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026